A wide range of methods have been adopted for the determination of glycated haemoglobin (either HbA 1 HbA 1 or total glycated haemoglobin G-D 1 Hb) and have been reviewed recently. Meth?ds relying on the change in charge from glycation (Ion-exchange chromatography and electr?endosmosis) and methods relying on a change In structure (immunoassay) are susceptible to interference from abnormal haernoglobins.'
chro~atography3 and ion-capture affinity") all involve a separation step. We present here the preliminary results from the development of a novel, fluorescent, non-separation affinity method for the determination of total glycated haemoglobin. The principle of the method is that the emission of certain fluorescent derivatives of boronic acids is quenched when bound to glycated haemoglobin but not when unbound.
MATERIALS AND METHODS
Preparation of f1uorescein-boronic acid derivative Fluorescein-5-isothiocyanate (Sigma; Poole, UK) was mixed with 3-aminophenyl boronic acid (Aldrich; Gillingham, UK) and the product purified by thin layer chromatograp.hy..Th~full method is reported in a patent application, pH 8.5 buffer Glycine 7·51 g (AnalaR, BOH; Poole, Dorset, UK) and 10·16 g magnesium chloride hexa-Correspondence: S Blincko. 140 hydrate (AnalaR, BOH) were dissolved i.n I L water (hypersolve, BOH). The pH was adjusted to 8·5 by addition of concentrated sodium hydroxide solution.
Specificity of the reagent HbA and HbA I were purified from the lysate of washed red blood cells by ion-exchange chromatography using columns and reagents from a mini-column glycated haemoglobin [HbAd kit (Sigma). The method was followed except that 30 J-lL washed red cells rather than 50 J-lL of whole blood lysate was added to 200 J-lL lysing butTer. The buffers of the two fractions (HbA I and HbA) obtained from the columns were changed by ge1filtration (PO 10 columns, Pharmacia Biotechnology, Uppsala, Sweden) to the pH 8·5 butTer. Absorbances (00 4 15 ) of the resultant eluates were measured by photometry (Cecil 5233) and a series of dilutions added to the fluorescein-boronic acid derivative (5 nrnol/L) in the pH 8·5 buffer. After 50 min the fluorescence intensity was recorded (Perkin-Elmer LS20 filter fluorimeter: excitation 480 nm, emission 520 nm).
Lysing buffer for red cells A 0·2% solution of triton X-IOO (BOH) was prepared in the pH 8·5 buffer.
Quenching response with clinical samples Twenty-five samples (EDTA whole blood) were taken from a diabetic clinic. 50 J-lL packed red cells from the settled unwashed whole blood samples were lysed in 450 J-lL lysing buffer. After incubation for 30 min 20 J-lL lysate was added (in duplicate) to 2 mL 5 nrnol/L fluorescein-boronic acid compound in the pH 8·5 buffer. After 50 min the fluorescence intensity was recorded. The HbA I values were compared to results obtained by the Corning Glytrac electroendosmosi.s method in routine use at St Bartholomew's Hospital. %HbA1 Corning Glytrac gave dose-responsive quenching of fluorescence: HbA only slightly quenched the fluorescence at similar concentrations. Quenching was expressed as the drop in intensity between the fluorescent solution without purified haemoglobin and the fluorescent solution with purified haemoglobin (Fig. I) .
RESULTS
Red blood cell Iysates (from 25 clinical specimens) were directly mixed with the fluorescent reagent (Fig. 2) . Three samples were heterozygous HbAjS. The glycated %haemoglobin was estimated as the %HbA I + %HbS I of the total HbA + HbS. Quenching was expressed as the drop in intensity between the fluorescent solution without sample lysate and the intensity of the fluorescent solution with sample lysate (expressed as arbitrary units of intensity, Fig. 2) . The quenching observed correlated well (r=0'911) with the results obtained for the same samples by the electroendosmosis method.
DISCUSSION
concentrations by the fluorescence quenching of 4-methylumbelliferone.
The results described in this report demonstrate the first step to developing a fluorescence non-separation assay for glycated haemoglobin. The quenching results (Fig. I) showed the fluorescent compound was capable of discriminating between HbA 1 and HbA. The potential for these findings to be the basis of an assay for the determination of total glycated haemoglobin is shown by the comparison with electrodendosmosis ( Fig. 2 ). There was good agreement between duplicate analyses of individual patient specimens and this suggests that a fully developed method could show good precision. This method is subject of a patent application' and is currently being developed into a simple and rapid assay suitable for the routine measurement of total glycated haemoglobin. 
